D. Cribbs

C. Cotman, W. V. Van Nostrand, D. Cribbs, 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Commentary Caspase-Mediated Degeneration in Alzheimer’s Disease

R. Rissman, D. Cribbs, W. Poon, 2004 .

β-Amyloid deposition and neurofibrillary tangle association with caspase activation in Down syndrome

C. Cotman, E. Head, D. Cribbs, 2002, Neuroscience Letters.

Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma.

Victor V Lobanenkov, D. Cribbs, D. Loukinov, 2011, Cellular immunology.

Reductions in Aβ-derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylation

F. LaFerla, D. Cribbs, N. Kim, 2014 .

Low concentrations of anti-Aβ antibodies generated in Tg2576 mice by DNA epitope vaccine fused with 3C3d molecular adjuvant do not affect AD pathology.

D. Cribbs, T. Ross, I. Petrushina, 2010, Human gene therapy.

Experimental Investigation of Antibody-Mediated Clearance Mechanisms of Amyloid-β in CNS of Tg-SwDI Transgenic Mice

W. V. Van Nostrand, V. Vasilevko, D. Cribbs, 2007, The Journal of Neuroscience.

Importance of IgG2c isotype in the immune response to β-amyloid in amyloid precursor protein/transgenic mice

V. Vasilevko, D. Cribbs, I. Petrushina, 2003, Neuroscience Letters.

Immunogenicity of MultiTEP-Platform-Based Recombinant Protein Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological α-Synuclein

E. Masliah, D. Cribbs, I. Petrushina, 2022, International journal of molecular sciences.

Brain Penetrating Bifunctional Erythropoietin-Transferrin Receptor Antibody Fusion Protein for Alzheimer's Disease.

V. Vasilevko, D. Cribbs, W. Pardridge, 2018, Molecular pharmaceutics.

Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study

Robert C. Green, Andrew J. Saykin, Liana G. Apostolova, 2020, Nature Communications.

Immunogenicity of epitope vaccines targeting different B cell antigenic determinants of human α-synuclein: Feasibility study

D. Cribbs, I. Petrushina, A. Ghochikyan, 2014, Neuroscience Letters.

Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies

E. Masliah, E. Rockenstein, D. Cribbs, 2022, npj Vaccines.

MultiTEP platform–based DNA vaccines for alpha-synucleinopathies: preclinical evaluation of immunogenicity and therapeutic potency

E. Masliah, D. Cribbs, I. Petrushina, 2017, Neurobiology of Aging.

Semi-automated protocol to quantify and characterize fluorescent three-dimensional vascular images

Danny F. Xie, Bernard Choi, D. Cribbs, 2022, bioRxiv.

Identification of N-terminally truncated pyroglutamate amyloid-β in cholesterol-enriched diet-fed rabbit and AD brain.

V. Vasilevko, D. Cribbs, G. Gevorkian, 2014, Journal of Alzheimer's disease : JAD.

Immunization with a vaccine that combines the expression of MUC1 and B7 co-stimulatory molecules prolongs the survival of mice and delays the appearance of mouse mammary tumors

G. Nicolson, V. Vasilevko, D. Cribbs, 2004, Clinical & Experimental Metastasis.

Anti-11[E]-pyroglutamate-modified amyloid β antibodies cross-react with other pathological Aβ species: Relevance for immunotherapy

T. Govezensky, V. Vasilevko, D. Cribbs, 2010, Journal of Neuroimmunology.

Blood brain barrier endothelial cells express candidate amyloid precursor protein-cleaving secretases.

D. Cribbs, C. Abraham, A. Billingslea, 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Elicitation of T Cell Responses to Histologically Unrelated Tumors by Immunization with the Novel Cancer-Testis Antigen, Brother of the Regulator of Imprinted Sites1

Victor V Lobanenkov, D. Loukinov, D. Cribbs, 2007, The Journal of Immunology.

Imprinted Sites Antigen, Brother of the Regulator of Immunization with the Novel Cancer-Testis Histologically Unrelated Tumors by Elicitation of T Cell Responses to

Victor V Lobanenkov, D. Loukinov, D. Cribbs, 2006 .

Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant

Victor V Lobanenkov, D. Loukinov, D. Cribbs, 2006, Journal of cellular biochemistry.

Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Nick C Fox, Michelle K. Lupton, Charles C. White, 2019, Nature Genetics.

Reducing AD-Like Pathology in 3xTg-AD Mouse Model by DNA Epitope Vaccine — A Novel Immunotherapeutic Strategy

E. Head, D. Cribbs, I. Petrushina, 2008, PloS one.

Delivery of a DNA Vaccine for Alzheimer’s Disease by Electroporation versus Gene Gun Generates Potent and Similar Immune Responses

D. Cribbs, I. Petrushina, A. Ghochikyan, 2012, Neurodegenerative Diseases.

BDNF-dependent synaptic plasticity is suppressed by IL-1 β via p38 MAPK

C. Cotman, D. Cribbs, E. Kramár, 2013 .

Brain endothelial cell enzymes cleave platelet-retained amyloid precursor protein.

D. Cribbs, A. Billingslea, E. Simons, 1998, The Journal of laboratory and clinical medicine.

Mimotopes of conformational epitopes in fibrillar β-amyloid

V. Vasilevko, D. Cribbs, I. Petrushina, 2004, Journal of Neuroimmunology.

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

C. Cotman, V. Vasilevko, D. Cribbs, 2003, International immunology.

Adjuvant-dependent modulation of T h 1 and T h 2 responses to immunization with b-amyloid

C. Cotman, V. Vasilevko, D. Cribbs, 2003 .

Complement activation by cross‐linked truncated and chimeric full‐length β‐amyloid

D. Cribbs, A. Tenner, C. Glabe, 1997, Neuroreport.

Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates

N. Petrovsky, D. Cribbs, I. Petrushina, 2022, npj Vaccines.

Monolayer and atomic force microscopy studies of nicotinic acetylcholine receptor films

C. A. Palmer, T. Fare, D. Cribbs, 1992, 1992 14th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid β peptide.

M. Lefranc, W. V. Van Nostrand, D. Cribbs, 2010, Molecular immunology.

Immunostimulant adjuvant patch enhances humoral and cellular immune responses to DNA immunization.

D. Cribbs, G. Glenn, T. Ross, 2008, DNA and cell biology.

DNA, but not protein vaccine based on mutated BORIS antigen significantly inhibits tumor growth and prolongs the survival of mice

Victor V Lobanenkov, D. Loukinov, D. Cribbs, 2008, Gene Therapy.

Therapeutic Modulation of Cerebral Microhemorrhage in a Mouse Model of Cerebral Amyloid Angiopathy

V. Vasilevko, D. Cribbs, G. F. Passos, 2011, Stroke.

The β-Amyloid Model of Alzheimer's Disease:Conformation Change, Receptor Cross-Linking, the Initiation of Apoptosis

C. Cotman, A. Anderson, D. Cribbs, 1996 .

Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease.

D. Cribbs, M. Fiala, M. Rosenthal, 2007, Journal of Alzheimer's disease : JAD.

Efficacy and Safety of a Brain-Penetrant Biologic TNF-α Inhibitor in Aged APP/PS1 Mice

Weijun Ou, D. Cribbs, R. Sumbria, 2022, Pharmaceutics.

A model of inflammation-induced cerebral microbleeds.

A. Paganini-Hill, M. Scadeng, V. Vasilevko, 2016 .

Comparative Analysis of H&E and Prussian Blue Staining in a Mouse Model of Cerebral Microbleeds

A. Paganini-Hill, V. Vasilevko, D. Cribbs, 2014, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch.

D. Cribbs, I. Petrushina, A. Ghochikyan, 2006, Vaccine.

Modulation of hepatic amyloid precursor protein and lipoprotein receptor-related protein 1 by chronic alcohol intake: Potential link between liver steatosis and amyloid-β

E. Cadenas, N. Kaplowitz, D. Cribbs, 2022, Frontiers in Physiology.

Simple methodology to visualize whole-brain microvasculature in three dimensions

Bernard Choi, Christian Crouzet, Katiana Khouri, 2021, Neurophotonics.

Mixed Cerebrovascular Disease and the Future of Stroke Prevention

V. Vasilevko, D. Cribbs, M. Fisher, 2012, Translational Stroke Research.

Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.

D. G. Clark, C. Carlson, K. Lunetta, 2014, JAMA neurology.

Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency

D. Cribbs, I. Petrushina, Joy L. Davis, 2017, Molecular Neurodegeneration.

Repeated Mild Closed Head Injuries Induce Long-Term White Matter Pathology and Neuronal Loss That Are Correlated With Behavioral Deficits

Brian J Cummings, V. Vasilevko, D. Cribbs, 2018, ASN neuro.

The progression of β-amyloid deposition in the frontal cortex of the aged canine

Brian J Cummings, C. Cotman, K. Nielson, 1997, Brain Research.

Reduction of Soluble Aβ and Tau, but Not Soluble Aβ Alone, Ameliorates Cognitive Decline in Transgenic Mice with Plaques and Tangles*

F. LaFerla, M. Kitazawa, A. Caccamo, 2006, Journal of Biological Chemistry.

Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease

C. Cotman, M. Sabbagh, N. Berchtold, 2014, Neurobiology of Aging.

Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity

C. Cotman, C. Pike, C. Glabe, 1995 .

Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity.

C. Cotman, C. Pike, C. Glabe, 1995, Journal of neurochemistry.

Microfluidic Multicompartment Device for Neuroscience Research.

Noo Li Jeon, C. Cotman, N. Jeon, 2003, Langmuir : the ACS journal of surfaces and colloids.

Agglutination of Plant Protoplasts by Fungal Cell Wall Glucans

D. Cribbs, B. Peters, D. Stelzig, 1978, Science.

Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer’s Disease Model

F. LaFerla, M. Kitazawa, V. Vasilevko, 2011, The Journal of Immunology.

Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease

Carl W. Cotman, Joseph Rogers, Paul D. Coleman, 2013, Neurobiology of Aging.

EXCEPTIONALLY LOW LIKELIHOOD OF ALZHEIMER'S DEMENTIA IN APOE2 HOMOZYGOTES

C. Carlson, Jonathan, K. Lunetta, 2019, medRxiv.

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Nick C Fox, Michelle K. Lupton, Charles C. White, 2019, Nature Genetics.

Activation of Caspase-8 in the Alzheimer's Disease Brain

William H. Nesse, C. Cotman, E. Head, 2001, Neurobiology of Disease.

Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer’s Disease

J. Padmanabhan, D. Cribbs, Alexander J. Rajic, 2017, eNeuro.

Presenilin-1 Immunoreactivity Is Localized Intracellularly in Alzheimer's Disease Brain, but Not Detected in Amyloid Plaques

F. LaFerla, L. Weber, C. Glabe, 1997, Experimental Neurology.

Genetic Ablation of Hematopoietic Cell Kinase Accelerates Alzheimer’s Disease–Like Neuropathology in Tg2576 Mice

M. Kitazawa, D. Cribbs, Christine Chen, 2020, Molecular Neurobiology.

Chronic kidney disease promotes cerebral microhemorrhage formation

Han Liu, A. Paganini-Hill, D. Cribbs, 2023, Journal of Neuroinflammation.

Aging exacerbates development of cerebral microbleeds in a mouse model

A. Paganini-Hill, V. Vasilevko, D. Cribbs, 2018, Journal of Neuroinflammation.

Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid

C. Cotman, C. Glabe, D. Cribbs, 2008, Journal of Neuroinflammation.

Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model.

M. Kitazawa, D. Cribbs, R. Medeiros, 2014, Journal of Alzheimer's disease : JAD.

Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer's Disease.

D. Cribbs, G. F. Passos, I. Petrushina, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Acta Neuropathologica ABCC 9 gene polymorphism is associated with hippocampal sclerosis of aging pathology

Farman, Charles D. Smith, Schneider, 2017 .

Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice

V. Vasilevko, D. Cribbs, I. Petrushina, 2008, Journal of Neuroinflammation.

Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study

C. Cotman, N. Berchtold, J. Rogers, 2012, Journal of Neuroinflammation.

Relapsing polychondritis with features of dementia with Lewy bodies

A. Starr, E. Head, D. Cribbs, 2006, Acta Neuropathologica.

Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease.

C. Cotman, B. Bahr, A. Anderson, 2001, The American journal of pathology.

Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice.

F. LaFerla, M. Kitazawa, D. Cribbs, 2013, The American journal of pathology.

Refinement of a DNA based Alzheimer disease epitope vaccine in rabbits

A. Kiyatkin, D. Cribbs, I. Petrushina, 2013, Human vaccines & immunotherapeutics.

DNA prime–protein boost increased the titer, avidity and persistence of anti-Aβ antibodies in wild-type mice

D. Cribbs, I. Petrushina, A. Ghochikyan, 2010, Gene Therapy.

The Induction of the TNFα Death Domain Signaling Pathway in Alzheimer's Disease Brain

Brian J Cummings, C. Cotman, A. Anderson, 2003, Neurochemical Research.

Inflammatory changes parallel the early stages of Alzheimer disease

C. Cotman, J. Rogers, V. Perreau, 2007, Neurobiology of Aging.

Complement Association with Neurons and β-Amyloid Deposition in the Brains of Aged Individuals with Down Syndrome

C. Cotman, E. Head, D. Cribbs, 2001, Neurobiology of Disease.

Prototype Alzheimer’s Disease Vaccine Using the Immunodominant B Cell Epitope from β-Amyloid and Promiscuous T Cell Epitope Pan HLA DR-Binding Peptide1

V. Vasilevko, D. Cribbs, I. Petrushina, 2005, The Journal of Immunology.

Generation and characterization of the humoral immune response to DNA immunization with a chimeric β‐amyloid‐interleukin‐4 minigene

E. Head, V. Vasilevko, D. Cribbs, 2003, European journal of immunology.

Fas and Fas Ligand are associated with neuritic degeneration in the AD brain and participate in β-amyloid-induced neuronal death

C. Cotman, A. Anderson, D. Cribbs, 2003, Neurobiology of Disease.

A fibril-specific, conformation-dependent antibody recognizes a subset of Aβ plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain

R. Kayed, D. Gillen, E. Head, 2009, Acta Neuropathologica.

15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis.

C. Cotman, D. Cribbs, S. Wong, 2001, Neuroreport.

Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline.

Frank M LaFerla, F. LaFerla, M. Kitazawa, 2011, The American journal of pathology.

Amyloid-β peptide binds to microtubule-associated protein 1B (MAP1B)

T. Govezensky, D. Cribbs, K. Manoutcharian, 2008, Neurochemistry International.

An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease

C. Cotman, D. Piomelli, G. Astarita, 2012, Neurobiology of Aging.

Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome

David H. Cribbs, J. Kesslak, F. LaFerla, 2004, Neuron.

Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy

E. Head, V. Vasilevko, D. Cribbs, 2010, Annals of the New York Academy of Sciences.

The mouse C1q A-chain sequence alters beta-amyloid-induced complement activation☆

T. Poulos, D. Cribbs, S. Webster, 1999, Neurobiology of Aging.

Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice

N. Petrovsky, D. Cribbs, I. Petrushina, 2019, Alzheimer's Research & Therapy.

Reductions in amyloid-beta-derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylation.

F. LaFerla, V. Vasilevko, D. Cribbs, 2010, Journal of Alzheimer's disease : JAD.

Blocking Aβ42 Accumulation Delays the Onset and Progression of Tau Pathology via the C Terminus of Heat Shock Protein70-Interacting Protein: A Mechanistic Link between Aβ and Tau Pathology

F. LaFerla, A. Caccamo, S. Oddo, 2008, The Journal of Neuroscience.

Anti-Aβ1–11 Antibody Binds to Different β-Amyloid Species, Inhibits Fibril Formation, and Disaggregates Preformed Fibrils but Not the Most Toxic Oligomers*

A. Kiyatkin, C. Glabe, D. Cribbs, 2007, Journal of Biological Chemistry.

Amyloid-β Peptide Binds to Cytochrome C Oxidase Subunit 1

D. Cribbs, K. Manoutcharian, G. Gevorkian, 2011, Alzheimer's & Dementia.

Immunodominant epitope and properties of pyroglutamate-modified Aβ-specific antibodies produced in rabbits

T. Govezensky, V. Vasilevko, D. Cribbs, 2009, Journal of Neuroimmunology.

Alzheimer’s disease AdvaxCpG- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules

N. Petrovsky, D. Cribbs, I. Petrushina, 2016, Scientific Reports.

Active immunization with tau epitope in a mouse model of tauopathy induced strong antibody response together with improvement in short memory and pSer396-tau pathology

N. Petrovsky, D. Cribbs, D. Morgan, 2020, Neurobiology of Disease.

Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials

A. Obenaus, D. Cribbs, I. Petrushina, 2020, Neurobiology of Disease.

Epitope-based DNA vaccine for Alzheimer's disease: Translational study in macaques

D. Cribbs, I. Petrushina, A. Ghochikyan, 2014, Alzheimer's & Dementia.

Rarity of the Alzheimer disease-protective APP A673T variant in the United States.

D. G. Clark, C. Carlson, K. Lunetta, 2015, JAMA neurology.

Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy

K. Parfitt, Weijun Ou, D. Cribbs, 2021, Journal of neuroinflammation.

Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid Immunotherapy

M. Sabbagh, C. Belden, T. Beach, 2013, PloS one.

Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.

D. Cribbs, 2010, CNS & neurological disorders drug targets.

Phagocytosis of Amyloid-β and Inflammation: Two Faces of Innate Immunity in Alzheimer's Disease

D. Cribbs, M. Fiala, M. Rosenthal, 2007 .

β amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: Usage of a novel blood brain barrier endothelial cell model system

D. Cribbs, E. Simons, P. Eisenhauer, 2000 .

β amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium : Usage of a novel blood brain barrier endothelial cell model system

D. Cribbs, E. Simons, P. Eisenhauer, 2000, Neurobiology of Aging.

Aspartate residue 7 in amyloid β-protein is critical for classical complement pathway activation: Implications for Alzheimer's disease pathogenesis

T. Poulos, D. Cribbs, A. Tenner, 1997, Nature Medicine.

Immunogenicity of DNA- and recombinant protein-based Alzheimer Disease epitope vaccines

D. Cribbs, I. Petrushina, A. Ghochikyan, 2014, Human vaccines & immunotherapeutics.

DNA epitope vaccine containing complement component C3d enhances anti-amyloid-β antibody production and polarizes the immune response towards a Th2 phenotype

D. Cribbs, T. Ross, I. Petrushina, 2008, Journal of Neuroimmunology.

Abeta-immunotherapy for Alzheimer's disease using mannan-amyloid-Beta peptide immunoconjugates.

V. Vasilevko, D. Cribbs, I. Petrushina, 2006, DNA and cell biology.

Non-plasma bonding of PDMS for inexpensive fabrication of microfluidic devices.

C. Cotman, N. Jeon, D. Cribbs, 2007, Journal of Visualized Experiments.

Localization and Cell Association of C1q in Alzheimer's Disease Brain

Brian J Cummings, C. Cotman, D. Cribbs, 1996, Experimental Neurology.

Title BDNF-dependent synaptic plasticity is suppressed by IL-1 β via p 38 MAPK Permalink

C. Cotman, D. Cribbs, E. Kramár, 2013 .

Mixed Cerebrovascular Disease and the Future of Stroke Prevention

Michael Fisher, V. Vasilevko, D. Cribbs, 2012, Translational Stroke Research.

Novel approaches for immunotherapeutic intervention in Alzheimer's disease

David H. Cribbs, V. Vasilevko, D. Cribbs, 2006, Neurochemistry International.

The MultiTEP platform–based Alzheimer's disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates

D. Cribbs, I. Petrushina, A. Ghochikyan, 2014, Alzheimer's & Dementia.

Novel amyloid-beta specific scFv and VH antibody fragments from human and mouse phage display antibody libraries

L. Vaca, T. Govezensky, V. Vasilevko, 2010, Journal of Neuroimmunology.

Epitope mapping and neuroprotective properties of a human single chain FV antibody that binds an internal epitope of amyloid-beta 1-42.

T. Govezensky, V. Vasilevko, D. Cribbs, 2008, Molecular immunology.

Modulation of a gated ion channel admittance in lipid bilayer membranes.

D A Stenger, D. Stenger, T. Fare, 1991, Biosensors & bioelectronics.

Brain-Derived Neurotrophic Factor-Dependent Synaptic Plasticity Is Suppressed by Interleukin-1β via p38 Mitogen-Activated Protein Kinase

G. Lynch, C. Cotman, D. Cribbs, 2012, The Journal of Neuroscience.

MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice.

D. Cribbs, I. Petrushina, Joy L. Davis, 2017, Vaccine.

Experimental hypertension increases spontaneous intracerebral hemorrhages in a mouse model of cerebral amyloidosis

V. Vasilevko, D. Cribbs, G. F. Passos, 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Decreased levels of C1q in cerebrospinal fluid of living Alzheimer patients correlate with disease state

C. Cotman, M. Smyth, J. Kesslak, 1994, Neurobiology of Aging.

Insights Into the Mechanisms of Brain Endothelial Erythrophagocytosis

A. Paganini-Hill, D. Cribbs, W. Lau, 2021, Frontiers in Cell and Developmental Biology.

The progression of beta-amyloid deposition in the frontal cortex of the aged canine.

Brian J Cummings, C. Cotman, K. Nielson, 1997, Brain research.

Spectroscopic and deep learning-based approaches to identify and quantify cerebral microhemorrhages

Danny F. Xie, Rachel H. Chae, Cody E. Dunn, 2021, Scientific Reports.

Using Digital Pathology to Identify and Quantify Cerebral Microhemorrhages

Danny F. Xie, Rachel H. Chae, Cody E. Dunn, 2021, Biophotonics Congress 2021.

Effects of Dabigatran in Mouse Models of Aging and Cerebral Amyloid Angiopathy

A. Paganini-Hill, V. Vasilevko, D. Cribbs, 2019, Front. Neurol..

Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90

Benjamin A. Logsdon, Cory C. Funk, John C. Earls, 2022, Scientific Reports.

Immunization with Amyloid-β Attenuates Inclusion Body Myositis-Like Myopathology and Motor Impairment in a Transgenic Mouse Model

F. LaFerla, M. Kitazawa, V. Vasilevko, 2009, Journal of Neuroscience.

Immunogenicity, Efficacy, Safety, and Mechanism of Action of Epitope Vaccine (Lu AF20513) for Alzheimer's Disease: Prelude to a Clinical Trial

A. Kiyatkin, L. Pedersen, D. Cribbs, 2013, The Journal of Neuroscience.

A Two-Year Study with Fibrillar β-Amyloid (Aβ) Immunization in Aged Canines: Effects on Cognitive Function and Brain Aβ

M. Hill, E. Head, V. Vasilevko, 2008, The Journal of Neuroscience.

Alzheimer's Disease Peptide Epitope Vaccine Reduces Insoluble But Not Soluble/Oligomeric Aβ Species in Amyloid Precursor Protein Transgenic Mice

E. Head, D. Cribbs, I. Petrushina, 2007, The Journal of Neuroscience.

Novel Aβ peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease

R. Kayed, C. Glabe, D. Cribbs, 2005, Journal of Neuroinflammation.

Microglial Function in Intracerebral Hemorrhage Injury and Recovery

D. Cribbs, Neethu Michael, A. Cho, 2018 .

Cultured Rat Microglia Express C1q and Receptor for C1q: Implications for Amyloid Effects on Microglia

C. Cotman, D. Cribbs, A. Tenner, 1995, Experimental Neurology.

Hematologic safety of chronic brain-penetrating erythropoietin dosing in APP/PS1 mice

D. Cribbs, W. Pardridge, R. Boado, 2019, Alzheimer's & dementia.

Blood-Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer's Disease.

V. Vasilevko, D. Cribbs, W. Pardridge, 2017, Molecular pharmaceutics.

Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated Abeta

C. Cotman, E. Head, V. Vasilevko, 2010, Neurobiology of Disease.

Immunization with fibrillar Aβ1–42 in young and aged canines: Antibody generation and characteristics, and effects on CSF and brain Aβ

C. Cotman, M. Murphy, N. Milgram, 2006 .

Pan HLA DR-Binding Peptide -Amyloid and Promiscuous T Cell Epitope b the Immunodominant B Cell Epitope from Prototype Alzheimer's Disease Vaccine Using

V. Vasilevko, D. Cribbs, I. Petrushina, 2005 .

The induction of the TNFalpha death domain signaling pathway in Alzheimer's disease brain.

Brian J Cummings, C. Cotman, A. Anderson, 2003, Neurochemical research.

Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccines

L. Pedersen, D. Cribbs, I. Petrushina, 2014, Journal of Neuroimmunology.

Fabrication of a microfluidic device for the compartmentalization of neuron soma and axons.

C. Cotman, N. Jeon, D. Cribbs, 2007, Journal of visualized experiments : JoVE.

Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice.

E. Head, D. Cribbs, I. Petrushina, 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Genetic Ablation of Hematopoietic Cell Kinase Accelerates Alzheimer’s Disease–Like Neuropathology in Tg2576 Mice

M. Kitazawa, D. Cribbs, Christine Chen, 2020, Molecular Neurobiology.

Anti-A beta 1-11 antibody binds to different beta-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils but not the most toxic oligomers.

A. Kiyatkin, C. Glabe, D. Cribbs, 2007, The Journal of biological chemistry.

The Effects of a Blood–Brain Barrier Penetrating Erythropoietin in a Mouse Model of Tauopathy

Weijun Ou, D. Cribbs, R. Sumbria, 2023, Pharmaceuticals.

Novel Vaccine against Pathological Pyroglutamate-Modified Amyloid Beta for Prevention of Alzheimer’s Disease

D. Cribbs, I. Petrushina, M. Blurton-Jones, 2023, International journal of molecular sciences.

Voltage modulation of a gated ion channel admittance in platinum-supported lipid bilayers

D. Stenger, T. Fare, D. Cribbs, 1992 .

Ion channel transduction in Langmuir-Blodgett lipid membranes

C. A. Palmer, D. Stenger, P. Bey, 1992 .

Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid

C. Cotman, C. Glabe, D. Cribbs, 2022 .

Novel Aβ peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease

R. Kayed, C. Glabe, D. Cribbs, 2005 .

Cerebral Blood Flow in Chronic Kidney Disease.

Bernard Choi, D. Cribbs, W. Lau, 2021, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis.

K. Lunetta, D. Geschwind, H. Hakonarson, 2020, JAMA neurology.

Microlithographic determination of axonal/dendritic polarity in cultured hippocampal neurons

Carl W. Cotman, James J. Hickman, Joseph J. Pancrazio, 1998, Journal of Neuroscience Methods.

Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency

D. Cribbs, I. Petrushina, Joy L. Davis, 2017, Molecular Neurodegeneration.

Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice

V. Vasilevko, D. Cribbs, I. Petrushina, 2008, Journal of Neuroinflammation.

Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting

Stephen R. Williams, C. Sudlow, J. Danesh, 2019, Neurology.

Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.

D. G. Clark, Jason J. Corneveaux, C. Carlson, 2014, JAMA neurology.

Frontal cortex neuropathology in dementia pugilistica.

P. Nelson, E. Head, D. Cribbs, 2012, Journal of neurotrauma.

Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.

C. Carlson, K. Lunetta, D. Geschwind, 2015, JAMA neurology.

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Genetic, Nick C Fox, Michelle K. Lupton, 2019, Nature Genetics.

Novel amyloid-beta specific scFv and VH antibody fragments from human and mouse phage display antibody libraries

T. Govezensky, V. Vasilevko, D. Cribbs, 2010, Journal of Neuroimmunology.

Gene expression changes in the course of normal brain aging are sexually dimorphic

C. Cotman, J. Trojanowski, S. Heinemann, 2008, Proceedings of the National Academy of Sciences.

A Two-Year Study with Fibrillar β-Amyloid (Aβ) Immunization in Aged Canines: Effects on Cognitive Function and Brain Aβ

M. Hill, E. Head, V. Vasilevko, 2008, The Journal of Neuroscience.

Aβ-Immunotherapy for Alzheimer's Disease Using Mannan–Amyloid-Beta Peptide Immunoconjugates

V. Vasilevko, D. Cribbs, I. Petrushina, 2006 .

Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies LRRC4C, LHX5-AS1 and nominates ancestry-specific loci PTPRK, GRB14, and KIAA0825 as novel risk loci for Alzheimer disease: the Alzheimer Disease Genetics Consortium

John X. Morris, Nicholas R. Wheeler, Timothy J. Hohman, 2023, medRxiv.

Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.

D. G. Clark, Jason J. Corneveaux, C. Carlson, 2014, JAMA neurology.

Novel Aβ peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease

R. Kayed, D. Cribbs, M. Fonseca, 2005, Journal of Neuroinflammation.

Langmuir-Blodgett studies and atomic force microscope images of nicotinic acetylcholine receptor films

C. A. Palmer, T. Fare, D. Cribbs, 1992 .

A Brain Penetrating Bifunctional Erythropoietin-Transferrin Receptor Antibody Fusion Protein for Alzheimer's Disease.

V. Vasilevko, D. Cribbs, W. Pardridge, 2019, Molecular Pharmaceutics.

Pavel P. Kuksa, Nicholas R. Wheeler, Timothy J. Hohman, 2023, medRxiv.

MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice.

D. Cribbs, I. Petrushina, Joy L. Davis, 2017, Vaccine.

The MultiTEP platform–based Alzheimer's disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates

D. Cribbs, I. Petrushina, A. Ghochikyan, 2014, Alzheimer's & Dementia.

Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid

D. Cribbs, C. Glabe, K. Nichol, 2008, Journal of Neuroinflammation.

Involvement of phosphoinositide 3-kinase gamma in the neuro-inflammatory response and cognitive impairments induced by beta-amyloid 1-40 peptide in mice

D. Cribbs, R. Prediger, G. F. Passos, 2010, Alzheimer's & Dementia.